Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study (Journal of Neurology, (2023), 10.1007/s00415-023-11700-7)
Academic Article
Publication Date:
2023
Short description:
Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study (Journal of Neurology, (2023), 10.1007/s00415-023-11700-7) / Zanetta, C., Rocca, M.A., Meani, A., Martinelli, V., Ferre, L., Moiola, L., Filippi, M.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 270:7(2023), pp. 3565-3566. [10.1007/s00415-023-11772-5]
abstract:
The original version of this article unfortunately contained a mistake. The several values in Table 1 have shifted up from the correct row. Category of N Previous treatments, N%” has 4 sub-entries, with which the values should be aligned. And the same is for “Type of Last Previous Treatments, N%”, which has 7 sub-entries with which the values should be aligned. The corrected Table 1 is given in the following page.
Iris type:
1.1.5. Erratum
List of contributors:
Zanetta, C.; Rocca, M. A.; Meani, A.; Martinelli, V.; Ferre, L.; Moiola, L.; Filippi, M.
Published in: